Aktuelle News
News Funktionen
Weitere Funktionen
23 April 2024
Laxxon Medical
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
28 März 2024
Laxxon Medical
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
18 Dezember 2023
Laxxon Medical
Laxxon Medical to Participate in 26th Annual Needham Growth Conference
6 Dezember 2023
Laxxon Medical
Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
16 November 2023
Laxxon Medical
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company’s inaugural globalization venture
6 November 2023
Laxxon Medical
Laxxon Medical to Attend BIO-Europe Munich 2023
17 Juli 2023
Laxxon Medical
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
6 Juli 2023
Laxxon Medical
3D screen printing technology enables fabrication of oral dosage forms with freely tailorable drug release profiles – technology and concept well suited for mass production
1 Juni 2023
Laxxon Medical
Laxxon Medical to participate in 2023 BIO International Convention
31 Mai 2023
Laxxon Medical
Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts to Support Pipeline and Life Cycle Management
17 April 2023
Laxxon Medical
Laxxon Medical to Participate in 22nd Annual Needham Virtual Healthcare Conference
27 März 2023
Laxxon Medical
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
2 Februar 2023
Laxxon Medical
Laxxon Medical to Participate in the BIO CEO & Investor Conference
5 Januar 2023
Laxxon Medical
Laxxon Medical to Participate in 25th Annual Needham Growth Conference
22 September 2022
Laxxon Medical
Laxxon Medical: Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms, Strengthening the Company’s Intellectual Property Position in Pharmaceutical Market
Laxxon Medical
Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs Within Pharmaceutical Dosage Forms, Strengthening the Company’s Intellectual Property Position in Pharmaceutical Market
9 März 2022
Laxxon Medical
Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
8 März 2022
Laxxon Medical
Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
Laxxon Medical
Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
16 Februar 2022
Laxxon Medical
‘Game Changing’ Technology Enables QR Code Integration with 3D Screen Printing
Laxxon Medical
‘Game Changing’ Technology Enables QR Code Integration with 3D Screen Printing
7 Januar 2022
Laxxon Medical
Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
Laxxon Medical
Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference